Microwave ablation: A new technique for the prophylactic management of idiopathic recurrent epistaxis

The objective of this study was to compare the re-bleeding of idiopathic recurrent epistaxis with no definite bleeding site treated with either prophylactic microwave ablation (MWA) or continuous observation. Case series with chart review. 61 patients with idiopathic recurrent epistaxis but no defin...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of otolaryngology Vol. 40; no. 5; pp. 696 - 699
Main Author Lou, Zheng-cai
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.09.2019
Elsevier Limited
Subjects
Online AccessGet full text
ISSN0196-0709
1532-818X
1532-818X
DOI10.1016/j.amjoto.2019.06.005

Cover

Abstract The objective of this study was to compare the re-bleeding of idiopathic recurrent epistaxis with no definite bleeding site treated with either prophylactic microwave ablation (MWA) or continuous observation. Case series with chart review. 61 patients with idiopathic recurrent epistaxis but no definite bleeding sites in the first operation were assigned to prophylactic MWA group (n = 39) and continuous observation group (n = 22). Patients in prophylactic MWA group were given prophylactic MWA at the common bleeding sites. Patients in continuous observation group were only observed in the ward. The bleeding sites, re-bleeding and complications were evaluated during 3 months follow-up period. Rebleeding was experienced by 7 of the patients (17.9%) who were treated with prophylactic MWA whereas, 13 of the patients (59.1%) who used continuous observation had rebleeding. The rebleeding rate for patients undergoing prophylactic MWA group was lower than that for the observation-only group (p < 0.01). All the ablations were completed for the patients with known bleeding site within 1–2 min. These patients only had the complain of slight postoperative pain, no serious complications (including nasal adhesion, crust, septal perforation, etc.) were found in the follow-up period. MWA is a simple, convenient, rapid, and definite hemorrhage control method with minimally invasive therapeutic technique. Prophylactic MWA at the common bleeding sites helps to significantly reduce the rate of rebleeding in patients in whom no definite bleeding sites have been identified.
AbstractList The objective of this study was to compare the re-bleeding of idiopathic recurrent epistaxis with no definite bleeding site treated with either prophylactic microwave ablation (MWA) or continuous observation. Case series with chart review. 61 patients with idiopathic recurrent epistaxis but no definite bleeding sites in the first operation were assigned to prophylactic MWA group (n = 39) and continuous observation group (n = 22). Patients in prophylactic MWA group were given prophylactic MWA at the common bleeding sites. Patients in continuous observation group were only observed in the ward. The bleeding sites, re-bleeding and complications were evaluated during 3 months follow-up period. Rebleeding was experienced by 7 of the patients (17.9%) who were treated with prophylactic MWA whereas, 13 of the patients (59.1%) who used continuous observation had rebleeding. The rebleeding rate for patients undergoing prophylactic MWA group was lower than that for the observation-only group (p < 0.01). All the ablations were completed for the patients with known bleeding site within 1-2 min. These patients only had the complain of slight postoperative pain, no serious complications (including nasal adhesion, crust, septal perforation, etc.) were found in the follow-up period. MWA is a simple, convenient, rapid, and definite hemorrhage control method with minimally invasive therapeutic technique. Prophylactic MWA at the common bleeding sites helps to significantly reduce the rate of rebleeding in patients in whom no definite bleeding sites have been identified.
The objective of this study was to compare the re-bleeding of idiopathic recurrent epistaxis with no definite bleeding site treated with either prophylactic microwave ablation (MWA) or continuous observation.OBJECTIVEThe objective of this study was to compare the re-bleeding of idiopathic recurrent epistaxis with no definite bleeding site treated with either prophylactic microwave ablation (MWA) or continuous observation.Case series with chart review.STUDY DESIGNCase series with chart review.61 patients with idiopathic recurrent epistaxis but no definite bleeding sites in the first operation were assigned to prophylactic MWA group (n = 39) and continuous observation group (n = 22). Patients in prophylactic MWA group were given prophylactic MWA at the common bleeding sites. Patients in continuous observation group were only observed in the ward. The bleeding sites, re-bleeding and complications were evaluated during 3 months follow-up period.SUBJECTS AND METHODS61 patients with idiopathic recurrent epistaxis but no definite bleeding sites in the first operation were assigned to prophylactic MWA group (n = 39) and continuous observation group (n = 22). Patients in prophylactic MWA group were given prophylactic MWA at the common bleeding sites. Patients in continuous observation group were only observed in the ward. The bleeding sites, re-bleeding and complications were evaluated during 3 months follow-up period.Rebleeding was experienced by 7 of the patients (17.9%) who were treated with prophylactic MWA whereas, 13 of the patients (59.1%) who used continuous observation had rebleeding. The rebleeding rate for patients undergoing prophylactic MWA group was lower than that for the observation-only group (p < 0.01). All the ablations were completed for the patients with known bleeding site within 1-2 min. These patients only had the complain of slight postoperative pain, no serious complications (including nasal adhesion, crust, septal perforation, etc.) were found in the follow-up period.RESULTSRebleeding was experienced by 7 of the patients (17.9%) who were treated with prophylactic MWA whereas, 13 of the patients (59.1%) who used continuous observation had rebleeding. The rebleeding rate for patients undergoing prophylactic MWA group was lower than that for the observation-only group (p < 0.01). All the ablations were completed for the patients with known bleeding site within 1-2 min. These patients only had the complain of slight postoperative pain, no serious complications (including nasal adhesion, crust, septal perforation, etc.) were found in the follow-up period.MWA is a simple, convenient, rapid, and definite hemorrhage control method with minimally invasive therapeutic technique. Prophylactic MWA at the common bleeding sites helps to significantly reduce the rate of rebleeding in patients in whom no definite bleeding sites have been identified.CONCLUSIONSMWA is a simple, convenient, rapid, and definite hemorrhage control method with minimally invasive therapeutic technique. Prophylactic MWA at the common bleeding sites helps to significantly reduce the rate of rebleeding in patients in whom no definite bleeding sites have been identified.
ObjectiveThe objective of this study was to compare the re-bleeding of idiopathic recurrent epistaxis with no definite bleeding site treated with either prophylactic microwave ablation (MWA) or continuous observation.Study designCase series with chart review.Subjects and methods61 patients with idiopathic recurrent epistaxis but no definite bleeding sites in the first operation were assigned to prophylactic MWA group (n = 39) and continuous observation group (n = 22). Patients in prophylactic MWA group were given prophylactic MWA at the common bleeding sites. Patients in continuous observation group were only observed in the ward. The bleeding sites, re-bleeding and complications were evaluated during 3 months follow-up period.ResultsRebleeding was experienced by 7 of the patients (17.9%) who were treated with prophylactic MWA whereas, 13 of the patients (59.1%) who used continuous observation had rebleeding. The rebleeding rate for patients undergoing prophylactic MWA group was lower than that for the observation-only group (p < 0.01). All the ablations were completed for the patients with known bleeding site within 1–2 min. These patients only had the complain of slight postoperative pain, no serious complications (including nasal adhesion, crust, septal perforation, etc.) were found in the follow-up period.ConclusionsMWA is a simple, convenient, rapid, and definite hemorrhage control method with minimally invasive therapeutic technique. Prophylactic MWA at the common bleeding sites helps to significantly reduce the rate of rebleeding in patients in whom no definite bleeding sites have been identified.
Author Lou, Zheng-cai
Author_xml – sequence: 1
  givenname: Zheng-cai
  surname: Lou
  fullname: Lou, Zheng-cai
  email: louzhengcai@163.com
  organization: Department of Otorhinolaryngology, Yiwu Central Hospital, 699, Jiangdong Road, Yiwu City, Zhejiang Province, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31229366$$D View this record in MEDLINE/PubMed
BookMark eNqFkU2LFDEYhIOsuLOr_0Ak4MVLt_nqdHoRYVn8ghUvCt5CJv22k7E7aZP0rvPvzTirh7nMKZD3qaKoukBnPnhA6DklNSVUvt7WZtqGHGpGaFcTWRPSPEIr2nBWKaq-n6FVOciKtKQ7RxcpbQkhXPDmCTrnlLGOS7lC8NnZGO7NHWCzHk12wV_ha-zhHmewG-9-LYCHEHHeAJ5jmDe70djsLJ6MNz9gAp9xGLDrXZhN3pRDBLvEuP-H2aVsfrv0FD0ezJjg2cN7ib69f_f15mN1--XDp5vr28oKwXNliaS9YkyuRUPZmra2Y8yAaixpG2GhIVIOoMRAhSRNQ0UnO9KBarkSikHLL9Grg29JWoKnrCeXLIyj8RCWpBkTknHBeFfQl0foNizRl3SFUpQIRVtVqBcP1LKeoNdzdJOJO_2vwAKIA1BaTCnC8B-hRO930lt92Envd9JE6rJTkV0dyazLf9vP0bjxlPjtQQylyjsHUSfrwFvoXek-6z64UwZvjgzs6LyzZvwJu9PyP8rVw_k
CitedBy_id crossref_primary_10_1016_j_amjoto_2021_102916
crossref_primary_10_1186_s40463_021_00520_2
crossref_primary_10_1016_j_amjoto_2020_102494
crossref_primary_10_1016_j_amjoto_2020_102492
crossref_primary_10_1016_j_amjoto_2020_102519
Cites_doi 10.1002/alr.22304
10.1080/00016489.2018.1552016
10.1016/j.anl.2015.09.015
10.1097/01.mlg.0000161365.96685.6c
10.1017/S0022215110000411
10.1007/s12070-010-0054-0
10.1080/02656736.2017.1388929
10.1177/014556130408300913
10.2147/OTT.S151219
ContentType Journal Article
Copyright 2019 Elsevier Inc.
Copyright © 2019 Elsevier Inc. All rights reserved.
2019. Elsevier Inc.
Copyright_xml – notice: 2019 Elsevier Inc.
– notice: Copyright © 2019 Elsevier Inc. All rights reserved.
– notice: 2019. Elsevier Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7QR
7TK
8FD
FR3
K9.
NAPCQ
P64
7X8
DOI 10.1016/j.amjoto.2019.06.005
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Nursing & Allied Health Premium
Biotechnology Research Abstracts
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
Chemoreception Abstracts
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Nursing & Allied Health Premium


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-818X
EndPage 699
ExternalDocumentID 31229366
10_1016_j_amjoto_2019_06_005
S0196070919303977
Genre Journal Article
Comparative Study
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID --K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1CY
1P~
1RT
1~.
1~5
23M
3O-
4.4
457
4CK
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABJNI
ABLJU
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACIWK
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKEYQ
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CAG
COF
CS3
EBS
EFJIC
EFKBS
EJD
EMOBN
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
GROUPED_DOAJ
HEA
HMK
HMO
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
LZ2
M29
M41
MO0
N4W
N9A
O-L
O9-
OAUVE
OG-
OR0
OZT
P-8
P-9
PC.
PQQKQ
PROAC
Q38
R2-
ROL
RPZ
SAE
SDF
SDG
SDP
SEL
SES
SEW
SJN
SSH
SSZ
SV3
T5K
WH7
WOW
WUQ
X7M
Z5R
ZGI
~G-
3V.
7RV
7X7
8FI
AACTN
AAIAV
ABLVK
ABYKQ
AFKRA
AFKWA
AHPSJ
AJBFU
AJOXV
AMFUW
AZQEC
BENPR
EFLBG
FYUFA
GUQSH
LCYCR
M1P
M2O
RIG
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7QR
7TK
8FD
FR3
K9.
NAPCQ
P64
7X8
ID FETCH-LOGICAL-c443t-c061d8226b4512b17c922ae85c0754ce5066fe84f1460551496909e8738482e73
IEDL.DBID AIKHN
ISSN 0196-0709
1532-818X
IngestDate Thu Sep 04 19:01:53 EDT 2025
Sat Jul 26 02:19:46 EDT 2025
Wed Feb 19 02:28:59 EST 2025
Thu Apr 24 23:09:46 EDT 2025
Tue Jul 01 03:15:19 EDT 2025
Fri Feb 23 02:30:36 EST 2024
Tue Aug 26 18:39:46 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Observation
Epistaxis
Microwave ablation
Re-bleeding
Language English
License Copyright © 2019 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c443t-c061d8226b4512b17c922ae85c0754ce5066fe84f1460551496909e8738482e73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
PMID 31229366
PQID 2281048178
PQPubID 1226367
PageCount 4
ParticipantIDs proquest_miscellaneous_2246234239
proquest_journals_2281048178
pubmed_primary_31229366
crossref_primary_10_1016_j_amjoto_2019_06_005
crossref_citationtrail_10_1016_j_amjoto_2019_06_005
elsevier_sciencedirect_doi_10_1016_j_amjoto_2019_06_005
elsevier_clinicalkey_doi_10_1016_j_amjoto_2019_06_005
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September-October 2019
2019-09-00
2019 Sep - Oct
20190901
PublicationDateYYYYMMDD 2019-09-01
PublicationDate_xml – month: 09
  year: 2019
  text: September-October 2019
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Maryland Heights
PublicationTitle American journal of otolaryngology
PublicationTitleAlternate Am J Otolaryngol
PublicationYear 2019
Publisher Elsevier Inc
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier Limited
References Guo, Tian, Zhao, Jiang (bb0030) 2018; 11
Thornton, Mahesh, Lang (bb0015) 2005; 115
Paul, Kanotra, Kanotra (bb0050) 2011; 63
Iimura, Hatano, Ando, Arai, Arai, Shigeta (bb0005) 2016; 43
Zhou, Wu, Ling, Zhu, Lu, Wang (bb0025) 2018; 34
Lou, Wei, Lou (bb0040) 2019
Lou, Dong, Lou (bb0035) 2019
Bhatnagar, Berry (bb0045) 2004; 83
Supriya, Shakeel, Veitch, Ah-See (bb0010) 2010; 124
Liu, Sun, Guo, Wang (bb0020) 2016; 95
Liu (10.1016/j.amjoto.2019.06.005_bb0020) 2016; 95
Supriya (10.1016/j.amjoto.2019.06.005_bb0010) 2010; 124
Guo (10.1016/j.amjoto.2019.06.005_bb0030) 2018; 11
Bhatnagar (10.1016/j.amjoto.2019.06.005_bb0045) 2004; 83
Paul (10.1016/j.amjoto.2019.06.005_bb0050) 2011; 63
Iimura (10.1016/j.amjoto.2019.06.005_bb0005) 2016; 43
Lou (10.1016/j.amjoto.2019.06.005_bb0040) 2019
Thornton (10.1016/j.amjoto.2019.06.005_bb0015) 2005; 115
Zhou (10.1016/j.amjoto.2019.06.005_bb0025) 2018; 34
Lou (10.1016/j.amjoto.2019.06.005_bb0035) 2019
32334920 - Am J Otolaryngol. 2020 Nov - Dec;41(6):102494
32334924 - Am J Otolaryngol. 2020 Nov - Dec;41(6):102492
References_xml – volume: 34
  start-page: 1049
  year: 2018
  end-page: 1052
  ident: bb0025
  article-title: Application of microwave ablation in the emergent control of intraoperative life-threatening tumor hemorrhage during hepatic surgeries
  publication-title: Int J Hyperthermia
– volume: 63
  start-page: 141
  year: 2011
  end-page: 144
  ident: bb0050
  article-title: Endoscopic management of posterior epistaxis
  publication-title: Indian J Otolaryngol Head Neck Surg
– volume: 83
  start-page: 633
  year: 2004
  end-page: 634
  ident: bb0045
  article-title: Selective surgicel packing for the treatment of posterior epistaxis
  publication-title: Ear Nose Throat J
– volume: 115
  start-page: 588
  year: 2005
  end-page: 590
  ident: bb0015
  article-title: Posterior epistaxis: identification of common bleeding sites
  publication-title: Laryngoscope
– volume: 43
  start-page: 298
  year: 2016
  end-page: 303
  ident: bb0005
  article-title: Study of hemostasis procedures for posterior epistaxis
  publication-title: Auris Nasus Larynx
– volume: 11
  start-page: 1395
  year: 2018
  end-page: 1402
  ident: bb0030
  article-title: Fast hemostasis: a win-win strategy for ultrasound and microwave ablation
  publication-title: Onco Targets Ther
– volume: 124
  start-page: 744
  year: 2010
  end-page: 749
  ident: bb0010
  article-title: Epistaxis: prospective evaluation of bleeding site and its impact on patient outcome
  publication-title: J Laryngol Otol
– year: 2019
  ident: bb0035
  article-title: Microwave ablation for the treatment of arterial epistaxis: “how I do it”
  publication-title: Int Forum Allergy Rhinol
– year: 2019
  ident: bb0040
  article-title: Identification of bleeding sites and microwave thermal ablation of posterior epistaxis
  publication-title: Acta Otolaryngol
– volume: 95
  start-page: E18
  year: 2016
  end-page: E22
  ident: bb0020
  article-title: Posterior epistaxis: common bleeding sites and prophylactic electrocoagulation
  publication-title: Ear Nose Throat J
– year: 2019
  ident: 10.1016/j.amjoto.2019.06.005_bb0035
  article-title: Microwave ablation for the treatment of arterial epistaxis: “how I do it”
  publication-title: Int Forum Allergy Rhinol
  doi: 10.1002/alr.22304
– year: 2019
  ident: 10.1016/j.amjoto.2019.06.005_bb0040
  article-title: Identification of bleeding sites and microwave thermal ablation of posterior epistaxis
  publication-title: Acta Otolaryngol
  doi: 10.1080/00016489.2018.1552016
– volume: 43
  start-page: 298
  year: 2016
  ident: 10.1016/j.amjoto.2019.06.005_bb0005
  article-title: Study of hemostasis procedures for posterior epistaxis
  publication-title: Auris Nasus Larynx
  doi: 10.1016/j.anl.2015.09.015
– volume: 95
  start-page: E18
  year: 2016
  ident: 10.1016/j.amjoto.2019.06.005_bb0020
  article-title: Posterior epistaxis: common bleeding sites and prophylactic electrocoagulation
  publication-title: Ear Nose Throat J
– volume: 115
  start-page: 588
  year: 2005
  ident: 10.1016/j.amjoto.2019.06.005_bb0015
  article-title: Posterior epistaxis: identification of common bleeding sites
  publication-title: Laryngoscope
  doi: 10.1097/01.mlg.0000161365.96685.6c
– volume: 124
  start-page: 744
  year: 2010
  ident: 10.1016/j.amjoto.2019.06.005_bb0010
  article-title: Epistaxis: prospective evaluation of bleeding site and its impact on patient outcome
  publication-title: J Laryngol Otol
  doi: 10.1017/S0022215110000411
– volume: 63
  start-page: 141
  year: 2011
  ident: 10.1016/j.amjoto.2019.06.005_bb0050
  article-title: Endoscopic management of posterior epistaxis
  publication-title: Indian J Otolaryngol Head Neck Surg
  doi: 10.1007/s12070-010-0054-0
– volume: 34
  start-page: 1049
  year: 2018
  ident: 10.1016/j.amjoto.2019.06.005_bb0025
  article-title: Application of microwave ablation in the emergent control of intraoperative life-threatening tumor hemorrhage during hepatic surgeries
  publication-title: Int J Hyperthermia
  doi: 10.1080/02656736.2017.1388929
– volume: 83
  start-page: 633
  year: 2004
  ident: 10.1016/j.amjoto.2019.06.005_bb0045
  article-title: Selective surgicel packing for the treatment of posterior epistaxis
  publication-title: Ear Nose Throat J
  doi: 10.1177/014556130408300913
– volume: 11
  start-page: 1395
  year: 2018
  ident: 10.1016/j.amjoto.2019.06.005_bb0030
  article-title: Fast hemostasis: a win-win strategy for ultrasound and microwave ablation
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S151219
– reference: 32334924 - Am J Otolaryngol. 2020 Nov - Dec;41(6):102492
– reference: 32334920 - Am J Otolaryngol. 2020 Nov - Dec;41(6):102494
SSID ssj0003435
Score 2.2230256
Snippet The objective of this study was to compare the re-bleeding of idiopathic recurrent epistaxis with no definite bleeding site treated with either prophylactic...
ObjectiveThe objective of this study was to compare the re-bleeding of idiopathic recurrent epistaxis with no definite bleeding site treated with either...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 696
SubjectTerms Ablation
Adult
Bleeding
Cohort Studies
Comorbidity
Complications
Endoscopy
Epistaxis
Epistaxis - prevention & control
Epistaxis - therapy
Female
Hemorrhage
Hospitals
Humans
Male
Microwave ablation
Microwaves - therapeutic use
Middle Aged
Nose
Observation
Observation - methods
Otolaryngology
Pain
Patients
Perforation
Prognosis
Prospective Studies
Radiofrequency Ablation - methods
Re-bleeding
Recurrence
Risk Assessment
Systemic diseases
Treatment Outcome
Title Microwave ablation: A new technique for the prophylactic management of idiopathic recurrent epistaxis
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0196070919303977
https://dx.doi.org/10.1016/j.amjoto.2019.06.005
https://www.ncbi.nlm.nih.gov/pubmed/31229366
https://www.proquest.com/docview/2281048178
https://www.proquest.com/docview/2246234239
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS-NAEB-0wuGL3JdaT2UPfM21-5Vs7q3ISe-O-nIKvi2b7RYitilaP578251JNgFBUe4l0CRDt5PdmV-6v_kNwNEw8CIzqSfxQZ8oo3TilBziIS30VHMvai29yWk6Pld_LvTFGhy3tTBEq4yxv4npdbSOZwbRm4NlWQ7-kbILTtgcIciQYMw6bAiZp7oHG6Pff8enXUCWqumzyYlviwZtBV1N83Lzy2pFVYA8r4U8qY_dyxnqNQRaZ6KTj7AVISQbNaP8BGth8Rk-TOIm-RcIEyLZ3bu7wFzRUN1-shFD_Mw6xVaGWJUh9mP4bejoq7pUis07LgyrZqycllXdsNiza_pXnnScWFgS4Hwob77C-cmvs-NxErspJF4puUo8Zu4pwoG0UJjkC575XAgXjPaIGpQPGsHHLBg147RVijgqxxfnPJhMGmVEyOQ29BbVIuwCk07gspYFVy4omXkjvdPcBK2yAhHhsA-y9aD1UWqcOl5c2ZZTdmkbv1vyu62pdboPSWe1bKQ23rhftw_HtmWkGPgs5oI37LLO7tlUe4flfjsHbFzqN1YIw0l0JzN9-N5dxkVKOy9uEapbukchzCStxT7sNHOn-4mSC4Rcabr338P6Bpv0qWG-7UNvdX0bDhAqrYpDWP_xyA_jgngCOSUQxg
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7RrdRyQfQFy6N1pV7TXcd27HBDCLRtWS4FiZvleL1SEGxWsAuc-O3MOA9UqYiqlxxij5JMbM-X-JtvAL4NAy-0yTyJD_pEGqkSJ8UQD1mhJor7NGrpjU-y0Zn8ea7OV-CgzYUhWmWz9tdrelytmzODxpuDeVkOfpOyCw7YHCHIkGDMK3gtldDE6_v-8MTzELKussmJbYvd2_y5SPJyVxfVgnIAeR5lPKmK3d_j03P4M8aho3VYawAk26_v8R2shNl7eDNutsg_QBgTxe7O3Qbmiprotsf2GaJn1um1MkSqDJEfw6uhmy9johS76pgwrJqyclJWsVyxZ9f0T55UnFiYE9y8L28-wtnR4enBKGlqKSReSrFIPMbtCYKBrJAY4guufZ6mLhjlETNIHxRCj2kwcsppoxRRVI6fzXkwWhhp0qDFJ-jNqlnYBCZcipNaFFy6IIX2RninuAlK6gLx4LAPovWg9Y3QONW7uLQto-zC1n635HcbiXWqD0lnNa-FNl7or9qXY9skUlz2LEaCF-x0Z_fHQPsHy512DNhmot_YNDWcJHe06cPXrhmnKO27uFmoltRHIsgkpcU-bNRjp3tEwVMEXFm29d-39QXejk7Hx_b4x8mvbVillpoDtwO9xfUy7CJoWhSf46R4BIhhEZE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Microwave+ablation%3A+A+new+technique+for+the+prophylactic+management+of+idiopathic+recurrent+epistaxis&rft.jtitle=American+journal+of+otolaryngology&rft.au=Lou%2C+Zheng-cai&rft.date=2019-09-01&rft.pub=Elsevier+Inc&rft.issn=0196-0709&rft.eissn=1532-818X&rft.volume=40&rft.issue=5&rft.spage=696&rft.epage=699&rft_id=info:doi/10.1016%2Fj.amjoto.2019.06.005&rft.externalDocID=S0196070919303977
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0196-0709&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0196-0709&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0196-0709&client=summon